THE EFFECT OF AVACOPAN, A COMPLEMENT C5A RECEPTOR INHIBITOR, ON KIDNEY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS WITH RENAL DISEASE

被引：0
|
作者：
Jayne, David [1 ]
Merkel, Peter [2 ]
Bekker, Pirow [3 ]
McMahon, Jeffrey [3 ]
Schall, Thomas J. [3 ]
机构：
[1] Univ Cambridge, Dept Med, Cambridge, England
[2] Hosp Univ Penn, Div Rheumatol, 3400 Spruce St, Philadelphia, PA 19104 USA
[3] ChemoCentryx Inc, Mountain View, CA USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FC032
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PULMONARY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Dieterich, Johannes
    Hellmich, Bernhard
    Mahrhold, Juliane
    Feng, You-Shan
    El Rai, Abdallah
    Nessyt, Felix
    Specks, Ulrich
    Hetzel, Juergen
    Loeffler, Christian
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2024, 41 (02)
  • [32] Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis
    Su-Fang Chen
    Feng-Mei Wang
    Zhi-Ying Li
    Feng Yu
    Ming-Hui Zhao
    Min Chen
    Arthritis Research & Therapy, 17
  • [33] Reclassifying ANCA-associated vasculitis: a focus on kidney disease
    Berke, Ilay
    Kronbichler, Andreas
    LANCET RHEUMATOLOGY, 2024, 6 (11): : e736 - e737
  • [34] RENAL FUNCTION IN ANCA-ASSOCIATED VASCULITIS IS ASSOCIATED WITH ENT INVOLVEMENT
    Rahmattulla, C.
    van Wijngaarden, R. A. de Lind
    Berden, A. E.
    Hauer, H. A.
    Flossmann, O.
    Jayne, D. R.
    Gaskin, G.
    Rasmussen, N.
    Noel, L. -H.
    Ferrario, F.
    Waldherr, R.
    Wolterbeek, R.
    Goceroglu, A.
    Pusey, C. D.
    Hagen, C. E.
    Bruijn, J. A.
    Bajema, I. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 552 - 552
  • [35] Plasma complement factor H is associated with disease activity of patients with ANCA-associated vasculitis
    Chen, Su-Fang
    Wang, Feng-Mei
    Li, Zhi-Ying
    Yu, Feng
    Zhao, Ming-Hui
    Chen, Min
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [36] Thyroid Disease in Patients with ANCA-Associated Vasculitis
    Kermani, Tanaz
    Cuthbertson, David
    Carette, Simon
    Khalidi, Nader
    Koening, Curry L.
    Langford, Carol
    McAlear, Carol
    Monach, Paul
    Moreland, Larry
    Pagnoux, Christian
    Seo, Philip
    Specks, Ulrich
    Sreih, Antoine
    Warrington, Kenneth
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [37] Avacopan versus a Prednisone Taper in Patients with ANCA-Associated Vasculitis Without Kidney Involvement in a Phase 3 Trial
    Pagnoux, Christian
    Neel, Antoine
    Bray, Sarah
    Gurlin, Rachel E.
    Trimpe, Darcy
    Jayne, David
    Merkel, Peter
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5038 - 5040
  • [38] ANCA-ASSOCIATED VASCULITIS IN END STAGE RENAL DISEASE
    Wang, Song
    Wang, Yue
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1556 - 1556
  • [39] C5A RECEPTOR INHIBITOR AVACOPAN IN IGA NEPHROPATHY STUDY
    Bruchfeld, Annette
    Nachman, Patrick
    Parikh, Samir
    Lafayette, Richard
    Potarca, Antonia
    Diehl, Janet
    Lohr, Lisa
    Miao, Shichang
    Schall, Thomas
    Bekker, Pirow
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [40] SUCCESSFUL STEROID REPLACEMENT IN ANCA-ASSOCIATED VASCULITIS WITH C5A RECEPTOR INHIBITOR CCX168 IN PHASE 2 RANDOMISED TRIAL (CLEAR)
    Jayne, David
    Bruchfeld, Annette
    Harper, Lorraine
    Schaier, Matthias
    Venning, Michael
    Hamilton, Patrick
    Burst, Volker
    Grundman, Franziska
    Jadoul, Michel
    Szombati, Istvan
    Tesar, Vladimir
    Segelmark, Marten
    Potarca, Antonia
    Schall, Thomas J.
    Bekker, Pirow
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 45 - 45
12345